Galaxy Life Sciences Retains MidPoint Engineering to Commence Design Services for New Biomanufacturing Facility at The Reactory

Galaxy Life Sciences, LLC (Galaxy) has retained MidPoint Engineering [...]

By |2021-08-31T17:07:44+00:00August 31st, 2021|In the press, Reactory|0 Comments

Tax Deal Endorsed For $60 million WuXi Biologics Project In Worcester

Worcester Telegram - March 2020
The City Council Economic Development Committee Monday night unanimously endorsed a 20-year tax increment financing plan for the project that would save the company roughly $11.5 million in property taxes over the life of the plan. During that period, the city would receive $20.7 million in new tax revenue from the project. Learn More

By |2020-05-16T17:02:52+00:00March 16th, 2020|In the press, Latest Publications|0 Comments

Industry Veteran Matthew Zicaro Joins Development Firm to Form Galaxy Life Sciences

January 2020
Zicaro will lead team efforts in the acquisition, design, construction and leasing of state-of-the-art facilities supporting biopharmaceutical research, development, and manufacturing operations. Learn More

By |2021-12-14T14:20:11+00:00November 2nd, 2017|In the press, Latest Publications|0 Comments
Go to Top